157359-99-4

Basic information

• Product Name: 2-Chloro-6-fluorophenacyl bromide 98%
• Synonyms: 2-Chloro-6-fluorophenacyl bromide 98%;2-Bromo-2'-chloro-6'-fluoroacetophenone, 2-Bromo-1-(2-chloro-6-fluorophenyl)ethan-1-one;2-fluoro-6-chlorophenacylbroMide;2-Bromo-1-(2-chloro-6-fluorophenyl)ethanone;2-BroMo-2'-chloro-6'-fluoroacetophenone;2-Chloro-6-fluorophenacylbromide98%
• CAS NO: 157359-99-4
• Molecular Formula: C₈H₅BrClFO
• Molecular Weight: 251
• Mol File: 157359-99-4.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 2-Chloro-6-fluorophenacyl bromide 98%(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-6-fluorophenacyl bromide 98%(157359-99-4)
• EPA Substance Registry System: 2-Chloro-6-fluorophenacyl bromide 98%(157359-99-4)

Safety Data

• Hazardous Substances Data: 157359-99-4(Hazardous Substances Data)

Usage

General Description

2-Chloro-6-fluorophenacyl bromide 98% is a chemical compound that is used in the synthesis of various pharmaceuticals and organic compounds. It is a highly pure form of the compound, with a concentration of 98%. This chemical is a derivative of phenacyl bromide and is commonly used as a reagent in organic synthesis, particularly in the preparation of fluorinated compounds. It is a versatile chemical that can be used in a variety of reactions, making it valuable in the pharmaceutical and chemical industries. However, due to its reactive nature and potential hazards, it should be handled with care and in accordance with proper safety procedures.

Upstream product

• 87327-69-3 1-(2-chloro-6-fluorophenyl)ethan-1-one 

Downstream Products

• 1333906-50-5 2-((9H-purin-6-yl)thio)-1-(2-chloro-6-fluorophenyl)ethanone 

Relevant articles and documents

METHODS OF USE FOR OPSIN BINDING LIGANDS

Methods of use of compounds of the Formula I1 II, III, IV and/or V are disclosed for treating ophthalmic conditions related to the production of toxic visual cycle products that accumulate in the eye, and are associated with reactions of the visual cycle during medical procedures that expose the eye to light, most commonly the various forms of ophthalmic surgery and stabilize the proper folding of mutant opsins. Compounds and compositions useful in the these methods, either alone or in combination with other therapeutic agents, are also described, along with methods of screening for new agents useful in said treatments.

Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use

Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically active metabolites, and pharmaceutically acceptable salts of said metabolites are described. These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.